About this episode

This episode explores how Phenylketonuria (PKU) transformed newborn screening in the U.S. and its ongoing impact on public health and genetics.

What condition helped spark the creation of newborn screening in the United States? It was Phenylketonuria, or PKU, a rare inherited metabolic disorder that forever changed how we identify and treat genetic conditions from the very start of life. In this in-person episode of DNA Today, we kick off a three-part series on phenylketonuria, better known as PKU, by looking at how one condition became central to a major public health shift. Host Kira Dineen is joined in person by Sarah Chamberlin and Ryan Miller to explore the scientific, clinical, historical, and deeply personal sides of PKU. We explore the history of newborn screening itself, including the work of Dr. Robert Guthrie and the development of the Guthrie card. Sarah brings a remarkable piece of history to the recording: the original stamp used to create early Guthrie cards. Ryan, Sarah, and Kira unpack why PKU remains both a newborn screening success story and an ongoing challenge. From treatment access and medical nutrition coverage to state-by-state differences in newborn screening panels and the promise and complexity of newborn sequencing, this episode shows why PKU is still shaping conversations about genetics…

Sponsors

PTC Therapeutics

More episodes of DNA Today: A Genetics Podcast

• #403 Genetic Counseling Boards Prep: ABGC’s New Resources · July 17, 2026 · 31 min
• #402 How Genetic Genealogy Caught the Golden State Killer · July 10, 2026 · 24 min
• #401 The First Precision Medicine for Achondroplasia with Dr. Ravi Savarirayan · July 3, 2026 · 37 min
• #400 The Story Behind "DNA Today" · June 26, 2026 · 35 min

Explore listener stats, chart rankings, contacts and more on the DNA Today: A Genetics Podcast podcast page.